A detailed history of Engineers Gate Manager LP transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 39,685 shares of BMEA stock, worth $99,609. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,685
Holding current value
$99,609
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$3.88 - $12.41 $153,977 - $492,490
39,685 New
39,685 $153,000
Q4 2023

Feb 14, 2024

BUY
$8.37 - $19.8 $359,491 - $850,410
42,950 New
42,950 $623,000

Others Institutions Holding BMEA

About Biomea Fusion, Inc.


  • Ticker BMEA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,290,600
  • Market Cap $73.5M
  • Description
  • Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...
More about BMEA
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.